• AOBiome is a Boston-based biotech company focused on transforming human health through products that restore ammonia-oxidizing bacteria (AOB). The company...
    9 KB (895 words) - 10:36, 16 July 2024
  • 2014, it was being tested by the biotech company AOBiome for its possible health benefits on skin. AOBiome started a Phase II trial of an intranasal formulation...
    3 KB (220 words) - 05:06, 19 February 2024
  • lateral sclerosis (ALS) in December 1998. He is currently a director at AOBiome, as well as founder and CEO of PatientsLikeMe. Conceived while James Heywood...
    9 KB (934 words) - 18:57, 29 August 2024
  • participants. In 2017 Science 37 then completed a site-less trial for AOBiome Therapeutics. This was the first “interventional, randomized, placebo-controlled...
    7 KB (582 words) - 17:59, 17 May 2024
  • Thumbnail for ICarbonX
    seven other companies including SomaLogic, HealthTell, PatientsLikeMe, AOBiome, GALT, Imagu and Robustnique. iCarbonX has raised over $600 million in...
    5 KB (444 words) - 03:48, 17 September 2024